Home
Live Updates
AbilityPharma closes €7 million round for metastatic pancreatic cancer drug ABTL0812 : comparemela.com
AbilityPharma closes €7 million round for metastatic pancreatic cancer drug ABTL0812
AbilityPharma closes €7 million round to fully fund its international Phase 2b clinical trial with the antitumor drug ABTL0812 in pancreatic cancer patients.
Related Keywords
Spain ,
France ,
Israel ,
Canada ,
Canadian ,
Svetoslava Georgieva ,
Carles Dom ,
Shermaine Tilley ,
Sara Secall ,
Spain Ministry Of Science ,
Life Sciences ,
Ability Pharmaceuticals ,
Life Sciences Fund Shermaine Tilley ,
Life Sciences Fund ,
European Union ,
Fund Board ,
Sciences Fund ,
Capital Cell ,
Public Private Collaborations ,
Strategic Lines ,
Next Generation ,
Executive Chairman ,
Managing Partner ,
Ability Pharma ,
General Partner Inveready ,
comparemela.com © 2020. All Rights Reserved.